|
|||||
|
|

Financial derivatives exchange CME Group (NASDAQ:CME) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 8.1% year on year to $1.65 billion. Its non-GAAP profit of $2.77 per share was 1% above analysts’ consensus estimates.
Is now the time to buy CME? Find out in our full research report (it’s free for active Edge members).
CME Group’s fourth quarter results aligned with Wall Street expectations, supported by broad-based growth across asset classes and expansion in retail participation. Management pointed to increased activity in interest rate, energy, metals, agricultural, and cryptocurrency products as key drivers. CEO Terrence Duffy emphasized that the launch of new event contracts and strong performance in retail-focused micro products contributed meaningfully to quarterly momentum. The company also highlighted the resilience and diversification of its customer base, noting continued healthy engagement from both institutional and retail clients amid volatile market conditions.
Looking ahead, CME Group’s management is focused on launching major initiatives such as securities clearing and 24/7 crypto trading, projects expected to drive new business and client engagement. The upcoming introduction of additional cryptocurrency futures and continued expansion of event contracts are designed to attract new user segments while maintaining capital efficiency for existing clients. CFO Lynne Fitzpatrick noted, “We are dedicated to continuously evolving our product set and offering, a commitment that requires strategic investment for growth.” Management also cautioned that expense growth will track these investments, with special attention to balancing innovation and cost discipline.
Management credited the quarter’s performance to strong execution in retail and crypto products, new product launches, and sustained market data revenue growth.
CME’s outlook hinges on continued product expansion, regulatory changes, and investments in technology to support long-term growth and operational leverage.
In the coming quarters, the StockStory team will closely monitor (1) the adoption and revenue contribution from new crypto and event contract products, (2) regulatory progress on securities clearing and cross-margining initiatives, and (3) the impact of dynamic pricing and fee adjustments across core asset classes. The scalability and efficiency of ongoing technology investments, such as the Google Cloud migration, will also be important markers of CME’s operational execution.
CME Group currently trades at $294.51, in line with $293.07 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).
The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
| Apr-15 | |
| Apr-14 | |
| Apr-10 | |
| Apr-08 | |
| Apr-08 | |
| Apr-08 | |
| Apr-07 | |
| Apr-07 | |
| Apr-07 | |
| Apr-02 | |
| Apr-02 | |
| Mar-24 | |
| Mar-24 | |
| Mar-24 | |
| Mar-24 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite